Our last live virtual event of 2021: a quick scientific tea break with Communication Specialist Dr. Emma Gibbin-Lameira, is now available on demand! Watch as Dr. Gibbin-Lameira presents a powerful cytotoxicity case study showing Nanolive’s unique live cell-based testing and high content analysis in 96-well plate.

Specifically, Dr. Gibbin-Lameira has shown that:

Multiplexed quantitative descriptors of cell morphology and composition at both the population (field of view) and single cell level can be combined with high spatio-temporal images to evaluate drug responses in parallel, over long periods of time
It is possible to quantify dose-response effects of drugs on living cells in a multi-well set-up where different concentrations and different drugs can be tested in parallel.

Watch Now!

Download Application Note

Read our latest news

Nanolive launches the LIVE Cell Death Assay

Sep 20, 2022 | News

A push-button, automated solution for profiling cell health and death Nanolive launches another ground-breaking tool in cell analysis: the LIVE Cell Death Assay, a push button, automated solution for profiling cell health, death, apoptosis and necrosis, label-free....

Exploring the potential Nanolive technology holds for phenotypic drug discovery

Aug 22, 2022 | News

We are very proud and excited to announce a new publication from Dr. José Padrón and lead author Adrián Puerta showing the benefits of using Nanolive’s label-free data analysis in Phenotypic Drug Discovery (PPD) programs. Dr. Padrón is a Professor at the Universidad...

The Smart Lipid Droplet Assay: what do Key Opinion Leaders say about it?

Aug 17, 2022 | News

For the launch of our new digital assay, the Smart Lipid Droplet Assay, several key opinion leaders from various pharmaceutical companies and institutions had the chance to try out Nanolive's new tool first hand. Check below how they’ve put the new tool to use, and...

More news